Statement 5 February 2020

WHO EB 146 Agenda Item 7.1: Universal health coverage: moving together to build a healthier world


Delivered by David Gleicher (MSD) as part of the UHC 2030 Private Sector Constituency

Geneva, 5 February, 2020: Universal Health Coverage means that all individuals and communities have access to quality essential health services without risk of financial hardship. The private sector is well-positioned to contribute to UHC efforts and already provides health products and services for many millions of people and communities globally. In some countries, the private sector provides over 60% of health services.

As part of the UHC2030 multi-stakeholder platform that promotes collaboration to accelerate progress towards universal health coverage, the UHC2030 Private Sector Constituency (UHC2030 PSC) welcomes the adoption of the Political Declaration on UHC and its call to address healthcare in a holistic manner and elevate UHC discussions beyond the ministries of health. UHC2030 PSC brings together a diverse set of actors within the health value chain such as service providers, health insurers, manufactures, distributors of medicine, health products and innovative technologies and beyond – to foster dialogue on how the private sector can better contribute towards UHC objectives. Our statement, released ahead of the high-level meeting on UHC last September, was the first time the private sector has collectively recognized the significant role it can play in achieving UHC and it outlines seven ways the private sector can and does contribute to UHC, as well as the role of governments and other stakeholders in creating an enabling environment for effective private sector engagement. One of these critical factors is the importance of clear processes for structured and meaningful engagement of all partners to move together on UHC.

The UHC2030 PSC is now committed to “actioning our statement” playing our part to support Member states in achieving UHC. Central to this will be strengthening linkages with other members of the global health community – civil society and government. In this regard we look forward to constructive and inclusive dialogue to ensure successful implementation.


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster